Mechanism | Medication |
---|---|
H-K pump blockers [Proton pump inhibitors (PPI)] | -Prazoles |
H2 antagonists | Cimetidine Ranitidine Famotidine Nizatidine |
PGE1 agonists | Misoprostol |
Antacids | Aluminum hydroxide Calcium carbonate Magnesium hydroxide |
Antimicrobials | Amoxicillin / Metronidazole Macrolides |
- | Bismuth |
- | Sucralfate |
Hernia | IL | Triangle | IIR | EIR |
---|---|---|---|---|
Indirect inguinal hernia | Above | - | + | + |
Direct inguinal hernia | Above | Inguinal | - | + |
Femoral hernia | Below | Femoral | - | - |
Mechanism | Medication |
---|---|
D2 antagonists | Metoclopramide Prochlorperazine Domperidone Droperidol |
5-HT4 agonists | Cisapride Mosapride |
Stimulants | Macrolides |
Mechanism | Medication | Indications |
---|---|---|
M antagonists | Scopolamine | Motion sickness |
D2 antagonists | Metoclopramide Prochlorperazine Domperidone Droperidol | Postoperation Chemotherapy |
5-HT3 antagonists | -Setrons | Postoperation Chemotherapy |
H1 antagonists | 1° Antihistamines | Motion sickness Morning sickness |
Neurokinin antagonists | Aprepitant | Chemotherapy |
Cannabinoid agonists | Dronabinol | Chemotherapy |
- | Corticosteroids | Chemotherapy |
Mechanism | Medication |
---|---|
5-HT4 agonists | Cisapride Mosapride |
Stimulants | Senna Bisacodyl |
Hyperosmotics | Magnesium Polyethylene glycol Lactulose Enema |
Emollients | Docusate |
Lubricants | Mineral oil |
Bulk-formers | Psyllium |
Crohn Disease | Ulcerative Colitis | |
---|---|---|
Involvement | Ileum & Colon | Colon & Rectum |
Pattern | Skip | Contiguous |
Depth | Transmural | Mucosal Submucosal |
Radiography | String sign | Lead pipe |
Colonoscopy | Cobblestones | Pseudopolyps |
Histology | Noncaseating granuloma | Crypt abscess |
Immunology | Th1 | Th2 |
Autoantibody | ASCA | Anti-MPO [p-ANCA] |
Risk of colorectal cancer | ↑ | ↑↑ |
Grade | Proplase | Reduction |
---|---|---|
1 | - | - |
2 | + | Spontaneous |
3 | + | Manual |
4 | + | Irreducible |
SAAG < 1.1 | SAAG > 1.1 | |
---|---|---|
Ascites TP < 2.5 | Nephrosis | Cirrhosis |
Ascites TP > 2.5 | Cancer Infection | Right heart failure Budd-Chiari syndrome |
Score | 1 | 2 | 3 |
---|---|---|---|
Ascites | Grade 0 | Grade 1 & 2 | Grade 3 & 4 |
Bilirubin | < 2 | 2 ~ 3 | > 3 |
Albumin | > 3.5 | 2.8 ~ 3.5 | < 2.8 |
Time :: prothrombin [INR] | < 1.7 | 1.7 ~ 2.3 | > 2.3 |
Encephalopathy | Grade 0 | Grade 1 & 2 | Grade 3 & 4 |
Shunt | Portal | System |
---|---|---|
Splenorenal [Warren] shunt | Splenic vein | Renal vein |
Mesocaval H graft | SMV | IVC |
Portacaval H graft | Portal vein | IVC |
End-to-side portacaval anastomosis | Portal vein | IVC |
Side-to-side portacaval anastomosis | Portal vein | IVC |
Transjugular intrahepatic portosystemic shunt (TIPS) | Portal vein | Hepatic vein |
Resectable | VI/EM | Child-Pugh Score | Management |
---|---|---|---|
+ | - | ≤ B | Hepatectomy Radiofrequency ablation (RFA) |
+ | - | C | Liver transplantation |
- | - | ≤ B | Transarterial chemoembolization (TACE) |
- | + | ≤ B | Chemotherapy |
- | ± | C | Supportive care |
Parameter | (0.957 × ln Cr + 0.378 × ln Bilirubin + 1.120 × ln INR) × 10 |
---|---|
Cr | Serum creatinine |
Bilirubin | Serum bilirubin |
INR | Serum INR |
Indirect | Direct | Mixed | |
---|---|---|---|
Serum indirect bilirubin | ↑ | - | ↑ |
Serum direct bilirubin | - | ↑ | ↑ |
Urine bilirubin | - | ↑ | ↑ |
Urine urobilinogen | ↑ | ↓ | - |
Tea-colored urine | - | + | + |
Clay-colored stool | - | + | + |
Disease | Pain | Fever | Bil |
---|---|---|---|
Cholelithiasis | ± | - | - |
Cholecystitis | + | + | - |
Choledocholithiasis | ± | - | ↑ |
Cholangitis | + | + | ↑ |